Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)
FIAT
1 other identifier
interventional
200
1 country
1
Brief Summary
The FIAT study is funded by the Innovationsfonds of the German Ministry of Health via the DLR Project Management Agency. The study will be conducted in up to 21 hospitals across Germany and in collaboration with 10 German public health insurance companies. The primary aim of this study is to compare Family-Based Treatment delivered via telehealth (FBT) with inpatient multimodal therapy (IMT) with respect to treatment outcomes and health economic data. The results of the study will serve as a basis for the decision on the inclusion of FBT in the German S3 guidelines and the future reimbursement of FBT by public health insurances in Germany.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2024
CompletedFirst Posted
Study publicly available on registry
January 6, 2025
CompletedStudy Start
First participant enrolled
January 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
February 13, 2025
February 1, 2025
2.2 years
December 9, 2024
February 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in %mBMI
The %mBMI is calcualted based on bodyweight and height, measured by the study team. Change is the difference between the baseline and 12 month %mBMI.
12 months
Secondary Outcomes (17)
Specific psychopathology for anorexia nervosa
At the beginning of the study, at the end of treatment (FBT Arm-average: 10 Months; IMT Arm-average: 4 Months; both up to 12 months), 6 months after baseline and 12 months after baseline.
Compulsive exercise
At the beginning of the study, at the end of treatment (FBT Arm-average: 10 Months; IMT Arm-average: 4 Months; both up to 12 months), 6 months after baseline and 12 months after baseline.
Depression
At the beginning of the study, at the end of treatment (FBT Arm-average: 10 Months; IMT Arm-average: 4 Months; both up to 12 months), 6 months after baseline and 12 months after baseline.
Occurrence of adverse events
At the beginning of the study, at the end of treatment (FBT Arm-average: 10 Months; IMT Arm-average: 4 Months; both up to 12 months), 6 months after baseline and 12 months after baseline.
Menstrual status
At the beginning of the study, at the end of treatment (FBT Arm-average: 10 Months; IMT Arm-average: 4 Months; both up to 12 months), 6 months after baseline and 12 months after baseline.
- +12 more secondary outcomes
Study Arms (2)
FBT
EXPERIMENTALfamily-based therapy as a stepped care model using telemedicine
IMT
ACTIVE COMPARATORinpatient multimodal therapy
Interventions
FBT is an intensive, manualized therapy in which the parents of those affected are closely involved in a resource-oriented manner by FBT-certified therapists. FBT takes place in 3 phases: in phase 1, the parents take responsibility for their child's weight gain. Phase 2 involves the gradual transfer of responsibility for eating back to the patient. Phase 3 focuses on individual issues of the children and adolescents, e.g. catching up on important developmental steps missed due to the illness.
comprehensive, patient-oriented and multidisciplinary approach to address eating disorders following the S3 joint German treatment guidelines in specialized hospitals. Includes individual psychotherapy, family sessions, body-oriented therapy, nutritional counseling, group therapy sessions, relaxation techniques, mindfulness practices, and skills training. Targeted weight gain per week is at least 500g.
Eligibility Criteria
You may qualify if:
- restrictive and bulimic subtypes of anorexia nervosa (ICD-10: F50.00; F50.01)
- inpatient treatment indication according to S3 guideline
- weight \< 3. BMI-percentile or
- weight \<10. percentile and psychiatric comorbidity/rapid weight loss/lack of weight gain during outpatient treatment over last three month
- planned inpatient treatment
- insured with one of the participating health insurance companies
- stable internet connection
You may not qualify if:
- weight \<67%mBMI
- acute self harm or danger to others
- acute psychosis or suicidal tendencies
- current substance abuse
- child abuse or domestic violence in the family
- insured with other health insurance company
- judicial placement order for inpatient treatment
- known, currently existing child protection problems or proceedings by the family court
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Charite University, Berlin, Germanylead
- Bielefeld Universitycollaborator
- Techniker Krankenkassecollaborator
- BARMERcollaborator
- AOK Niedersachsencollaborator
- Mobil Krankenkassecollaborator
- Meine Krankenkassecollaborator
- Medicalnetworks CJ GmbH & Co.KGcollaborator
- AOK Baden-Württembergcollaborator
- DAK Gesundheitcollaborator
- BIG-direktcollaborator
- mhpluscollaborator
- Bahn-BKKcollaborator
- OFFIS - Institut für Informatikcollaborator
- Prof. Daniel Le Grange, UCSFcollaborator
Study Sites (1)
Charité- Universitätsmedizin Berlin
Berlin, State of Berlin, 13353, Germany
Related Publications (3)
Krautter, Tonja, and James Lock. "Is manualized family-based treatment for adolescent anorexia nervosa acceptable to patients? Patient satisfaction at the end of treatment." Journal of Family Therapy 26.1 (2004): 66-82.
BACKGROUNDLindstedt K, Forss E, Elwin M, Kjellin L, Gustafsson SA. Adolescents with full or subthreshold anorexia nervosa in a naturalistic sample: treatment interventions and patient satisfaction. Child Adolesc Psychiatry Ment Health. 2020 May 2;14:16. doi: 10.1186/s13034-020-00323-9. eCollection 2020.
PMID: 32391079BACKGROUNDHaas V, Wechsung K, Kaiser V, Schmidt J, Raile K, Busjahn A, Le Grange D, Correll CU. Comparing family-based treatment with inpatient treatment in youth with anorexia nervosa eligible for hospitalization: A 12-month feasibility study. Int J Eat Disord. 2024 Feb;57(2):388-399. doi: 10.1002/eat.24098. Epub 2023 Dec 11.
PMID: 38082440BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christoph U Correll, MD
Charite University, Berlin, Germany
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinic Director
Study Record Dates
First Submitted
December 9, 2024
First Posted
January 6, 2025
Study Start
January 31, 2025
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
February 13, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share